Literature DB >> 10848795

Exclusive expression of G-CSF receptor on myeloid progenitors in bone marrow CD34+ cells.

Y Ebihara1, M J Xu, A Manabe, A Kikuchi, R Tanaka, S Kato, T Nakahata, K Tsuji.   

Abstract

Although granulocyte colony-stimulating factor (G-CSF) has been reported to act on cells of neutrophilic lineage, the administration of G-CSF to induce the mobilization of various haematopoietic progenitors into the circulation. We analysed the expression of receptors for G-CSF (G-CSFR) on human bone marrow and G-CSF-mobilized peripheral blood CD34+ cells, and examined the proliferation and differentiation capabilities of sorted CD34+G-CSFR+ and CD34+G-CSFR- cells using methylcellulose clonal culture. Flow cytometric analysis showed that G-CSFR was expressed on 14.9 +/- 4.9% of bone marrow CD34+ cells, most of which were included in CD34+CD33+ and CD34+CD38+ cell fractions. In clonal cultures, CD34+G-CSFR+ cells produced only myeloid colonies, whereas CD34+G-CSFR- cells produced erythroid bursts, megakaryocyte and multilineage colonies. When incubated with the cytokine cocktail for 5 d, CD34+G-CSFR- cells generated CD34+G-CSFR+ myeloid progenitors. In G-CSF-mobilized peripheral blood, CD34+ cells contained 10.8 +/- 5.8% of G-CSFR+ cells, most of which were also myeloid progenitors, although CD34+G-CSFR- cells contained a substantial number of myeloid progenitors. These results indicated that the expression of G-CSFR on CD34+ cells is restricted to myeloid progenitors, suggesting that the specific activity of G-CSF on myelopoiesis depends on the exclusive expression of its receptor on myeloid progenitors, and that the mobilization of various haematopoietic progenitors is not a direct effect of G-CSF in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848795     DOI: 10.1046/j.1365-2141.2000.01952.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1.

Authors:  Ombretta Salvucci; Kan Jiang; Paola Gasperini; Dragan Maric; Jinfang Zhu; Shuhei Sakakibara; Georgina Espigol-Frigole; Shushang Wang; Giovanna Tosato
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

2.  The zebrafish granulocyte colony-stimulating factors (Gcsfs): 2 paralogous cytokines and their roles in hematopoietic development and maintenance.

Authors:  David L Stachura; Ondrej Svoboda; Clyde A Campbell; Raquel Espín-Palazón; Ryan P Lau; Leonard I Zon; Petr Bartunek; David Traver
Journal:  Blood       Date:  2013-10-15       Impact factor: 22.113

3.  Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates.

Authors:  Sonja Loges; Thomas Schmidt; Peter Carmeliet
Journal:  Genes Cancer       Date:  2010-01

Review 4.  Ex vivo expansion of human hematopoietic stem cells.

Authors:  T Nakahata
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

5.  The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1.

Authors:  Maria de la Luz Sierra; Shuhei Sakakibara; Paola Gasperini; Ombretta Salvucci; Kan Jiang; Peter J McCormick; Marta Segarra; Jim Stone; Dragan Maric; Jinfang Zhu; Xiaolan Qian; Douglas R Lowy; Giovanna Tosato
Journal:  Blood       Date:  2010-03-04       Impact factor: 22.113

6.  Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells.

Authors:  Maria De La Luz Sierra; Paola Gasperini; Peter J McCormick; Jinfang Zhu; Giovanna Tosato
Journal:  Blood       Date:  2007-06-27       Impact factor: 22.113

7.  Efficacy of delayed administration of post-chemotherapy granulocyte colony-stimulating factor: evidence from murine studies of bone marrow cell kinetics.

Authors:  Maxim Yankelevich; Margaret A Goodell; Joseph Kaplan
Journal:  Exp Hematol       Date:  2007-10-18       Impact factor: 3.084

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.